Pacira BioSciences, Inc. (PCRX) Social Stream



Pacira BioSciences, Inc. (PCRX): $28.67

0.18 (+0.63%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add PCRX to Watchlist
Sign Up

PACIRA BIOSCIENCES INC (PCRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering PACIRA BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 12 $93 $54 $80.916 $26.66 203.51%
2021-12-08 12 $93 $54 $81.083 $26.66 204.14%
2021-12-10 12 $97 $54 $81.416 $26.66 205.39%
2022-01-07 13 $97 $54 $81.538 $26.66 205.84%
2022-01-13 13 $97 $54 $81.846 $26.66 207%
2022-02-25 13 $97 $54 $82.384 $26.66 209.02%
2022-03-01 13 $96 $54 $82.615 $26.66 209.88%
2022-04-14 11 $96 $54 $81.363 $26.66 205.19%
2022-05-05 11 $96 $54 $80.2 $26.66 200.83%
2022-05-13 10 $96 $54 $81.6 $26.66 206.08%
2022-06-01 9 $96 $54 $83.222 $26.66 212.16%
2022-06-15 8 $96 $54 $82.125 $26.66 208.05%
2022-07-21 8 $96 $54 $81.625 $26.66 206.17%
2022-08-01 8 $96 $54 $81.125 $26.66 204.29%
2022-08-02 8 $96 $54 $80.75 $26.66 202.89%
2022-08-04 8 $96 $54 $80.142 $26.66 200.61%
2022-09-21 8 $96 $54 $80.125 $26.66 200.54%
2022-10-13 7 $96 $54 $80.125 $26.66 200.54%
2022-10-17 8 $96 $54 $79.25 $26.66 197.26%
2022-11-02 8 $96 $54 $77.777 $26.66 191.74%
2022-11-04 9 $96 $54 $75.333 $26.66 182.57%
2022-11-15 9 $96 $54 $73.5 $26.66 175.69%
2022-12-21 9 $96 $50 $73.1 $26.66 174.19%
2023-01-05 9 $96 $50 $70.555 $26.66 164.65%
2023-01-06 9 $96 $50 $68.444 $26.66 156.73%
2023-01-17 9 $96 $50 $67.888 $26.66 154.64%
2023-01-31 9 $76 $50 $60.875 $26.66 128.34%
2023-02-10 9 $69 $50 $60 $26.66 125.06%
2023-02-14 9 $69 $50 $59.5 $26.66 123.18%
2023-03-01 10 $76 $50 $60.777 $26.66 127.97%
2023-04-20 10 $76 $50 $60.666 $26.66 127.55%
2023-05-01 10 $76 $50 $60.555 $26.66 127.14%
2023-05-05 10 $72 $50 $59.888 $26.66 124.64%
2023-07-04 10 $72 $50 $59.889 $26.66 124.64%
2023-07-13 10 $72 $50 $59.555 $26.66 123.39%
2023-07-21 9 $72 $50 $60.5 $26.66 126.93%
2023-07-25 9 $72 $48 $59.75 $26.66 124.12%
2023-08-03 9 $68 $48 $55.375 $26.66 107.71%
2023-08-09 9 $68 $46 $55.125 $26.66 106.77%
2023-10-13 10 $68 $46 $54.5 $26.66 104.43%
2023-10-23 10 $68 $46 $54.777 $26.66 105.47%
2023-11-03 10 $68 $42 $53.333 $26.66 100.05%
2023-11-06 10 $58 $42 $51.555 $26.66 93.38%
2023-11-07 10 $58 $38 $49.888 $26.66 87.13%

The Trend in the Analyst Price Target


Over the past 46 weeks, PCRX's average price target has gone down $23.21.

PCRX reports an average of 59.41% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-01 10 76 50 60.777 43.38 40.1%
2023-04-20 10 76 50 60.666 46.51 30.44%
2023-05-05 10 72 50 59.875 42.89 39.6%
2023-08-03 9 68 48 55.375 38.75 42.9%
2023-11-07 10 58 38 49.888 30.28 64.76%

PCRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.2 8 2 0 0 0 10

The Trend in the Broker Recommendations


Over the past 39 weeks, PCRX's average broker recommendation rating improved by 0.36.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • PACIRA BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is greater than 4634.86% of all US stocks.
  • In the context of Pharmaceutical Products stocks, PACIRA BIOSCIENCES INC's average analyst price target is greater than 4456.29% of them.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, PACIRA BIOSCIENCES INC's number of analysts covering the stock is greater than 3935.85% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, PACIRA BIOSCIENCES INC's variance in analysts' estimates is lower than -1713.64% of them.

In the Pharmaceutical Products industry, EBS, SUPN, and PBH are the three stocks most similar to PACIRA BIOSCIENCES INC regarding the price target and analyst recommendation information presented here.

Is PCRX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!